By expenditures
| Name | Title | Type |
|---|---|---|
| Javonna Latimore | Executive Director | Auditee |
| James Clausell | Managing Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 401175 | 2025 | 2026-05-12 | CLAUSELL & ASSOCIATES PC | $1.10M |
| 371400 | 2024 | 2025-10-28 | CLAUSELL & ASSOCIATES PC | $1.20M |
| 353107 | 2023 | 2025-04-09 | Clausell & Associates PC | $844,356 |
| 308581 | 2022 | 2024-06-11 | Clausell & Associates PC | $772,622 |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 401175 | 2025 | 2026-05-12 | 1214468 | 2025-003 | Material Weakness | Yes | ABCL |
| 401175 | 2025 | 2026-05-12 | 1214467 | 2025-003 | Material Weakness | Yes | ABCL |
| 401175 | 2025 | 2026-05-12 | 1214466 | 2025-003 | Material Weakness | Yes | ABCL |
| 401175 | 2025 | 2026-05-12 | 1214465 | 2025-003 | Material Weakness | Yes | ABCL |
| 401175 | 2025 | 2026-05-12 | 1214464 | 2025-003 | Material Weakness | Yes | ABCL |
| 401175 | 2025 | 2026-05-12 | 1214463 | 2025-003 | Material Weakness | Yes | ABCL |
| 401175 | 2025 | 2026-05-12 | 1214462 | 2025-003 | Material Weakness | Yes | ABCL |
| 401175 | 2025 | 2026-05-12 | 1214461 | 2025-003 | Material Weakness | Yes | ABCL |
| 353107 | 2023 | 2025-04-09 | 1130916 | 2023-003 | Significant Deficiency | Yes | ABCL |
| 353107 | 2023 | 2025-04-09 | 1130915 | 2023-003 | Significant Deficiency | Yes | ABCL |
| 353107 | 2023 | 2025-04-09 | 554474 | 2023-003 | Significant Deficiency | Yes | ABCL |
| 353107 | 2023 | 2025-04-09 | 554473 | 2023-003 | Significant Deficiency | Yes | ABCL |
| 308581 | 2022 | 2024-06-11 | 976997 | 2022-003 | Significant Deficiency | - | ABCL |
| 308581 | 2022 | 2024-06-11 | 976996 | 2022-003 | Significant Deficiency | - | ABCL |
| 308581 | 2022 | 2024-06-11 | 976995 | 2022-003 | Significant Deficiency | - | ABCL |
| 308581 | 2022 | 2024-06-11 | 976994 | 2022-003 | Significant Deficiency | - | ABCL |
| 308581 | 2022 | 2024-06-11 | 400555 | 2022-003 | Significant Deficiency | - | ABCL |
| 308581 | 2022 | 2024-06-11 | 400554 | 2022-003 | Significant Deficiency | - | ABCL |
| 308581 | 2022 | 2024-06-11 | 400553 | 2022-003 | Significant Deficiency | - | ABCL |
| 308581 | 2022 | 2024-06-11 | 400552 | 2022-003 | Significant Deficiency | - | ABCL |